搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
过去 24 小时
时间不限
过去 1 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
cnbctv18
15 小时
US FDA approves Biocon Biologics' YESINTEK for autoimmune diseases
YESINTEK works by targeting specific proteins that contribute to inflammation, offering a new treatment option for patients ...
India Infoline
8 小时
Biocon Secures FDA Approval for Innovative Autoimmune Drug YESINTEK
Collaboration with Janssen aims to fast-track the launch and enhance accessibility to YESINTEK for patients in need.
The Fence Post
7 小时
Amazon boss funds research into reducing methane in cattle via vaccines
Amazon boss Jeff Bezos has pledged millions of dollars into research to significantly cut methane emissions from cattle using ...
17 小时
Instil Bio's Strategic Shift To SYN-2510: A Speculative 'Buy' Opportunity
Instil Bio is a clinical-stage biotech focusing on personalized immunotherapy. Check out my recommendation for TIL stock.
Chattanooga Times Free Press
8 小时
Emory researchers find clues to COVID-19 severity in nasal swabs
Heading into the fifth U.S. winter of COVID-19, an Emory University lab has found the presence – or absence – of a particular ...
ndtvprofit
12 小时
Biocon Biologics Receives US FDA Nod For Yesintek, A Biosimilar to J&J's Stelara
Biocon Biologics Ltd (BBL) has received US Food and Drug Administration (FDA) approval for Yesintek, a biosimilar for Johnson ...
GoodNewsNetwork
9 小时
First New Treatment in 50 Years for Asthma Attacks and COPD ‘Could be a Game-Changer’
The first new treatment for asthma attacks in 50 years is a drug already available—and it’s 4x more effective than steroid ...
Daily
14 小时
Submit Clinical Data in Indian Subjects: CDSCO Panel Tells AstraZeneca on Trastuzumab ...
Trastuzumab deruxtecan is a targeted drug used to treat certain types of cancer: breast cancer, gastric or gastroesophageal ...
The Financial Express
11 小时
USFDA gives nod to Biocon Biologics’ biosimilar to treat Crohn’s disease
The biosimilar is approved for the treatment of Crohn’s disease, Ulcerative Colitis, Plaque Psoriasis and Psoriatic Arthritis ...
腾讯网
15 小时
荟萃分析验证ADC相比其他抗HER2疗法能为HER2阳性晚期乳腺癌带来显著 ...
ADC高效低毒,成为HER2阳性晚期乳腺癌患者的优选方案。人表皮生长因子受体2(HER2)在大约20-25%的乳腺癌中扩增或过表达,与乳腺癌细胞的增殖和侵袭能力密切相关[1]。其生物学行为表现为高复发、转移、耐药和预后不良[2]。常规治疗包括大分子单 ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈